Becroft D M, Smeeton W M, Stewart J H
Arch Dis Child. 1980 Mar;55(3):213-7. doi: 10.1136/adc.55.3.213.
Thyroid hyperplasia was identified at necropsy in 16 of 70 cases of haemolytic disease of the newborn due to rhesus isoimmunisation dying in the years 1959--76. No hyperplasia was found in the thyroids from 140 nonrhesus-affected infants matched for date of birth, bodyweight and length, and gestation, or in cases of haemolytic disease born before 1966. All 16 infants with thyroid hyperplasia had received intrauterine transfusions and the iodine-containing contrast media used for preliminary amniography were the only goitrogenic factors identified. Lipiodol, first used in 1966, was considered to have the greatest effect. The 16 infants with hyperplastic thyroids were less mature and smaller than 22 infants with normal thyroids who had been similarly exposed to contrast media. The high incidence of hyperplasia may be due to immaturity of the adaptive mechanisms which allow most normal individuals to escape the goitrogenic effects of iodine compounds.
在1959年至1976年间死亡的70例因恒河猴血型免疫所致新生儿溶血病尸检中,发现16例有甲状腺增生。在140例与上述病例出生日期、体重、身长及孕期相匹配的非恒河猴血型影响的婴儿甲状腺中,以及1966年前出生的溶血病病例中,均未发现增生。所有16例有甲状腺增生的婴儿均接受过宫内输血,用于初步羊膜造影的含碘造影剂是唯一确定的致甲状腺肿因素。1966年首次使用的碘油被认为作用最大。16例甲状腺增生婴儿比22例同样接触过造影剂但甲状腺正常的婴儿成熟度更低、体型更小。增生的高发生率可能是由于适应性机制不成熟,而这种机制能使大多数正常个体免受碘化合物的致甲状腺肿作用。